Gross Margin
12.25%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
5.24%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
15.25%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
4.12%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
10.70%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
39.18BTWD1.23B · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
47.45TWDUpdated Aug 19, 2026Quarterly Revenue Growth
30.20%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
5.40BTWD169.14M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
3.58BTWD112.19M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
2.05BTWD64.27M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
7.74%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
776.53MTWD24.31M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
-2.49BTWD-77.94M · vs all stocks (USD) Updated Aug 19, 2026Trailing Annual Dividend Rate
0.2700TWDUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.99%Updated Aug 19, 20265-Year Average Dividend Yield
4.05%Updated Aug 19, 2026Payout Ratio
94.03%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 40.3%.Updated Aug 19, 2026Minority Interest (Equity)
1.56BTWDFY2025 · Dec 31, 2025Revenue
36.47BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
32.90BTWDFY2025 · Dec 31, 2025Gross Profit
3.58BTWDFY2025 · Dec 31, 2025Operating Income
978.20MTWD30.62M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
1.12BTWDFY2025 · Dec 31, 2025Income Tax Expense
506.59MTWDFY2025 · Dec 31, 2025Net Income
608.79MTWDFY2025 · Dec 31, 2025EBIT
1.49BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.68BTWDFY2025 · Dec 31, 2025Research & Development
409.77MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
2.35BTWDFY2025 · Dec 31, 2025Other Operating Expenses
-158.61MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
160.69MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
375.95MTWDFY2025 · Dec 31, 2025EPS (Basic)
0.5400TWDFY2025 · Dec 31, 2025EPS (Diluted)
0.5400TWDFY2025 · Dec 31, 2025Basic Shares Outstanding
825.71MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
825.71MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-160.33MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
2.36BTWDFY2025 · Dec 31, 2025Free Cash Flow
966.27MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.69BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.12BTWDFY2025 · Dec 31, 2025Other Non-cash Items
342.86MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.10BTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-197.65MTWDFY2025 · Dec 31, 2025Capital Expenditures
-1.39BTWDFY2025 · Dec 31, 2025Net Acquisitions
0.00TWDFY2025 · Dec 31, 2025Sale of Investments
0.00TWDFY2025 · Dec 31, 2025Other Investing Activity
502.88MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-889.33MTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
2.16BTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-29.92BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-7.55MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-519.73MTWDFY2025 · Dec 31, 2025Other Financing Charges
-78.87MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.37BTWDFY2025 · Dec 31, 2025